Travere Therapeutics Inc (TVTX) Stock Analysis

Travere Therapeutics Inc (TVTX) is a publicly traded company in the HEALTHCARE sector. It trades at $42.96, carries a market capitalization of $4.39B. This page summarizes the public market data, fundamentals, and frequently asked questions for TVTX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $42.96
• Market Cap: $4.39B
• EPS: $-0.50
• 52-Week High: $48.61
• 52-Week Low: $13.88

Market Sentiment

Travere Therapeutics Inc currently has a Bullish sentiment score of 0.42.

About Travere Therapeutics Inc

Travere Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing innovative therapies for patients with rare diseases. Headquartered in San Diego, California, Travere leverages a robust pipeline aimed at addressing significant unmet medical needs, particularly in the fields of metabolic and genetic disorders. The company's commitment to transforming the lives of patients is underscored by its strategic partnerships and development programs de...

GNG Research Analysis

GNG Research scores Travere Therapeutics Inc (TVTX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TVTX.

Frequently Asked Questions

Does TVTX pay dividends?

Travere Therapeutics Inc (TVTX) does not currently pay a regular dividend.

What is TVTX's market cap?

Travere Therapeutics Inc (TVTX) has a market capitalization of $4.39B with a current stock price of $42.96.